Abstract 4142748: Direct Oral Anticoagulants Versus Aspirin for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Background: Embolic stroke of undetermined source (ESUS) represents approximately 20% of ischemic strokes. The optimal treatment strategy for secondary prevention remains uncertain for patients with ESUS. We aimed to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing the safety and efficacy of direct oral anticoagulants (DOACs) versus aspirin therapy in patients with a history of ESUS. Methods: PubMed, Embase, Cochrane and Web of science databases were systematically searched for eligible trials until March 2024. The primary outcome of interest was recurrent stroke. Major bleeding and clinically relevant non-major bleeding (CRNMB) were assessed as safety outcomes. We pooled hazard rations (HRs) with 95% confidence intervals (CIs) for analysis. Results: Four RCTs comparing direct oral anticoagulants (DOACs) versus aspirin were included comprising 13,970 patients, of whom 6,989 (50%) were randomized to the DOACs group. The mean follow-up was 16 months. Compared to aspirin, DOACs did not reduce the incidence of recurrent stroke (HR: 0.95; 95% CI: 0.81-1.09; p=0.44), ischemic stroke (HR: 0.91; 95% CI: 0.79-1.06; p=0.23), all-cause mortality (HR: 1.11; 95% CI: 0.87-1.42; p=0.40), and major bleeding (HR: 1.56; 95% CI: 0.85%-2.86; p=0.15). However, patients in the DOACs group presented significantly higher incidence of CRNMB (HR: 1.54; 95% CI: 1.23-1.92; p=0.0002) when compared with the aspirin group. Conclusion: Compared with aspirin, DOACs use was associated with an elevated risk of CRNMB and did not demonstrate superior efficacy in preventing recurrent stroke among patients with ESUS. <div class="acfifjfajpekbmhmjppnmmjgmhjkildl" id="acfifjfajpekbmhmjppnmmjgmhjkildl"> </div> <div class="acfifjfajpekbmhmjppnmmjgmhjkildl" id="acfifjfajpekbmhmjppnmmjgmhjkildl"> </div>
Authors
- Larissa Teixeira (ORCID: https://orcid.org/0009-0000-7714-7148)
- Thomaz Alexandre Costa (ORCID: https://orcid.org/0000-0003-1789-6694)
- Nicole Fernandez (ORCID: https://orcid.org/0000-0002-5374-8659)
- Guilherme Dagostin de Carvalho (ORCID: https://orcid.org/0000-0001-8587-875X)
- Tathiane Gibicoski (ORCID: https://orcid.org/0009-0005-6231-216X)
- Luciana Armaganijan (ORCID: https://orcid.org/0000-0003-3100-3557)
- Denilsa Navalha (ORCID: https://orcid.org/0009-0002-4805-0931)
- Juan Armando Talavera (ORCID: https://orcid.org/0009-0008-2409-7675)
Institutions
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Universidade de Fortaleza (BR)
- Universidade Federal de Campina Grande (BR)
- Mount Sinai Medical Center (US)
- Instituto Dante Pazzanese de Cardiologia (BR)
- University of Nebraska Medical Center (US)
- Universidad Católica Boliviana San Pablo (BO)
Publication Details
- Journal
- Circulation
- Published
- 2024-11-12
- DOI
- https://doi.org/10.1161/circ.150.suppl_1.4142748
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00